A Study of DS3610a in Participants With Advanced Solid Tumor
Recruiting now · Phase 1
Conditions studied: Solid Tumors, Metastatic Solid Tumors
In brief
This study is designed to assess the safety, tolerability, and efficacy of DS3610a, given as a single agent to participants with advanced or metastatic solid tumors.
Key facts
- Study ID
- NCT07159126
- Run by
- Daiichi Sankyo
- People needed
- 70
- Starts
- 2025-10-09
- Expected to finish
- 2031-02-01
- Last updated by the study team
- 2025-12-10
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- National Cancer Center Hospital — Chūōku, Japan (enrolling)
- National Cancer Center Hospital East — Kashiwa, Japan (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.